CancerIQ Officially Launches Lab Network to Increase Awareness and Accelerate Adoption of Genetic Testing

Labcorp Is Scheduled to Present at The 2020 Evercore ISI 3rd Annual HealthCONx Conference

November 25, 2020

LabCorp is scheduled to present at the 2020 Evercore ISI 3rd Annual HealthCONx conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Nov. 25, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today announced that members of the executive management team will participate in a virtual fireside chat at the 3rd Annual Evercore ISI HealthCONx Conference on Thursday, Dec. 3 at 1:50 p.m. ET.

Labcorp and QIAGEN Announce New therascreen PIK3CA Mutation Analysis Companion Diagnostic for Metastatic Breast Cancer

Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling Coalition (ACGP)